Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Acta Biomaterialia|January 25, 2015
Therapeutic-designed electrospun bone scaffolds: mesoporous bioactive nanocarriers in hollow fiber composites to sequentially deliver dual growth factorsMin Sil Kang, Joong-Hyun Kim, Rajendra K Singh, et al.
Nanoscale|April 2, 2016
Gene delivery nanocarriers of bioactive glass with unique potential to load BMP2 plasmid DNA and to internalize into mesenchymal stem cells for osteogenesis and bone regenerationTae-Hyun Kim, Rajendra K Singh, Min Sil Kang, et al.
Acta Biomaterialia|April 5, 2017
Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticlesMin Sil Kang, Rajendra K Singh, Tae-Hyun Kim, et al.
Biomaterials|February 16, 2018
Nanocements produced from mesoporous bioactive glass nanoparticlesMin Sil Kang, Na-Hyun Lee, Rajendra K Singh, et al.
Cell Death & Disease|April 24, 2025
SOX5 inhibition overcomes PARP inhibitor resistance in BRCA-mutated breast and ovarian cancerMithun Ghosh, Min Sil Kang, Nar Bahadur Katuwal, et al.
International Journal of Molecular Sciences|December 9, 2023
PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian CancerMithun Ghosh, Min Sil Kang, Nar Bahadur Katuwal, et al.
Biomaterials|December 21, 2020
Antibacterial, proangiogenic, and osteopromotive nanoglass paste coordinates regenerative process following bacterial infection in hard tissueJung Ju Seo, Nandin Mandakhbayar, Min Sil Kang, et al.
International Journal of Molecular Sciences|November 9, 2024
Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian CancerSa Deok Hong, Nar Bahadur Katuwal, Min Sil Kang, et al.
Cancers|October 14, 2023
Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial CancerYeong Gyu Jeong, Nar Bahadur Katuwal, Min Sil Kang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 29, 2023
Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancerNar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, et al.
Pageof 3